We have collected information about Local And Systemic Delivery Of Sirnas For Oligonucleotide Therapy for you. Follow the links to find out details on Local And Systemic Delivery Of Sirnas For Oligonucleotide Therapy.
https://www.ncbi.nlm.nih.gov/pubmed/19301643
Local and systemic delivery of siRNAs for oligonucleotide therapy. Takeshita F(1), Hokaiwado N, Honma K, Banas A, Ochiya T. Author information: (1)Section for Studies on Metastasis, National Cancer Center Research Institute, Tokyo, Japan.Author: Fumitaka Takeshita, Naomi Hokaiwado, Kimi Honma, Agnieszka Banas, Takahiro Ochiya
https://www.researchgate.net/publication/24215342_Local_and_Systemic_Delivery_of_siRNAs_for_Oligonucleotides_Therapy
Local and Systemic Delivery of siRNAs for Oligonucleotides Therapy Article in Methods in Molecular Biology 487:83-92 · February 2009 with 10 Reads How we measure 'reads'
https://link.springer.com/protocol/10.1007%2F978-1-60327-547-7_4
Oct 13, 2008 · Takeshita F., Hokaiwado N., Honma K., Banas A., Ochiya T. (2009) Local and Systemic Delivery of siRNAs for Oligonucleotides Therapy. In: Sioud M. (eds) siRNA and miRNA Gene Silencing. Methods in Molecular Biology (Methods and Protocols), vol 487.Author: Fumitaka Takeshita, Naomi Hokaiwado, Kimi Honma, Agnieszka Banas, Takahiro Ochiya
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554547/
Aug 01, 2015 · Beside this, the most common target organs are the liver and the eye. Martinez et al. recently wrote a very nice overview of different diseases that are targeted by, for example, siRNAs. 64. Treating diseases through targeting of a specific gene expressed in the liver is appealing because of the easy access of this organ by systemic delivery.Author: E LundinKarin, GissbergOlof, SmithC.I. Edvard
https://www.researchgate.net/publication/23266141_Challenges_and_Opportunities_for_Local_and_Systemic_Delivery_of_siRNA_and_Antisense_Oligonucleotides
Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides Article in Clinical Pharmacology & Therapeutics 84(5):628-32 · October 2008 with 83 Reads
https://www.sciencedirect.com/science/article/pii/S1818087614000646
However, the excellent therapeutic potential of siRNA for cancer therapy remains uncovered. It is necessary to introduce systemic routes of siRNA delivery to treat most cancers. As mentioned above, the design criteria of an in vivo, systemic siRNA delivery system should include biocompatibility, biodegradability, and non-immunogenicity ...Author: Cong-fei Xu, Jun Wang
https://www.sciencedirect.com/science/article/pii/S0009279719305757
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases ... as they act only on one mRNA target. siRNAs are responsible for gene silencing at the post transcriptional level by causing RNA interference (RNAi). ... McCaskill and co-workers studied the systemic delivery of cationic liposomes ...Author: Meenu Mehta, Deeksha, Devesh Tewari, Gaurav Gupta, Rajendra Awasthi, Harjeet Singh, Parijat Pandey, ...
https://www.nature.com/articles/3302838
Sep 05, 2006 · Hydrodynamic gene delivery, the first systemic delivery method for naked DNA, is a rapid injection of a large volume of naked DNA solution (e.g. 5 μg plasmid DNA injected in 5–8 s in 1.6 ml ...Author: Li Sd, Huang L
https://www.optcongress.com/oligonucleotide
CHI’s Oligonucleotide Discovery and Delivery conference reveals the latest strategies at the forefront of discovery, chemistry and delivery with in-depth sessions on new chemistries, novel delivery mechanisms and the most important preclinical and clinical advances.
https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.24382
Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl‐xL and cisplatin against prostate cancer ... enabling systemic delivery of siRNAs. 23 Takeshita et al. 23 previously showed the evidence of tumor targeted delivery of systemically ... Local or systemic administration of Bcl‐xL ...Author: Ping Mu, Shunji Nagahara, Naoki Makita, Yuzo Tarumi, Kenji Kadomatsu, Yoshifumi Takei
Searching for Local And Systemic Delivery Of Sirnas For Oligonucleotide Therapy?
You can just click the links above. The data is collected for you.
